Gilead and Merck & Co. believe pairing two of their closely watched, experimental drugs for HIV could offer patients a long-lasting and meaningful treatment option, and so have decided to team up to develop and market the combination.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,